Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

VALN
Valneva SE
stock NASDAQ ADR

Market Open
Aug 14, 2026 2:02:09 PM EDT
7.20USD+27.345%(+1.55)2,727,297
6.85Bid   6.92Ask   0.07Spread
Pre-market
Aug 14, 2026 9:29:30 AM EDT
6.99USD+23.717%(+1.34)85,684
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 20, 2022
10:36AM EST  Mid-Morning Market Update: Markets Open Higher; American Airlines Posts Narrower-Than-Expected Loss   Benzinga
07:40AM EST  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.25 A.M. ET).   RTTNews
Jan 6, 2022
08:24AM EST  The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales   Benzinga
05:52AM EST  Valneva Confirmed Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001   Benzinga
01:18AM EST  Valneva SE (VALN) confirmed the previously announced timelines of its clinical trials and regulatory submissions for inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. The company continues to expect potential regulatory approvals in the first quarter of 2022. Also, Valneva expects to report topline data for the elderly trial in the coming weeks.   RTTNews
01:07AM EST  Valneva Confirms Clinical Trial And Regulatory Submission Timelines For COVID-19 Vaccine Candidate VLA2001   RTTNews
Dec 22, 2021
07:11AM EST  Valneva Posts Positive Lot-to-Lot Consistency Data For Its Single-Dose Chikungunya Vaccine   Benzinga
Dec 16, 2021
08:20AM EST  The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street   Benzinga
02:00AM EST  Valneva SE (VALN), a French biotech company, said on Thursday that the initial data from its phase 1/2 study showed the third dose of its inactivated, adjuvanted vaccine candidate VLA2001 has significantly raised immunity against Covid-19.   RTTNews
01:13AM EST  Valneva Announces Positive Homologous Booster Data From Phase 1/2 Study Of COVID-19 Vaccine Candidate, VLA2001   RTTNews
Dec 8, 2021
08:19AM EST  The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom   Benzinga
Nov 26, 2021
07:08AM EST  The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.00 A.M. ET).   RTTNews
Nov 23, 2021
12:40PM EST  Valneva Reports Signed Purchase Deal With European Commission For Its Inactivated COVID-19 Vaccine, No Terms Disclosed   Benzinga
Nov 10, 2021
10:11AM EST  Mid-Morning Market Update: Markets Edge Lower; US Inflation Rate Increases To 6.2%   Benzinga
08:28AM EST  Valneva SE (VALN), a French specialty vaccine company, said on Wednesday that the European Commission or EC has approved a deal pursuant to which Valneva would supply up to 60 million doses of VLA2001, inactivated Covid-19 vaccine candidate, over two years, including approximately 27 million doses in 2022.   RTTNews
08:23AM EST  The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance   Benzinga
08:01AM EST  Valneva: EC Approves Deal To Supply 60 Mln Doses Of Inactivated COVID-19 Vaccine VLA2001   RTTNews
06:23AM EST  Valneva Announces European Commission Approval Of Advance Purchase Agreement For Up To 60M Doses Of Inactivated COVID-19 Vaccine VLA2001   Benzinga
Oct 29, 2021
06:14AM EDT  The following are some of the stocks making big moves in Friday's pre-market trading (as of 05.45 A.M. EDT).   RTTNews
Oct 27, 2021
06:13AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 05.55 A.M. EDT).   RTTNews
Oct 21, 2021
06:17AM EDT  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 06.05 A.M. EDT).   RTTNews
Oct 20, 2021
12:45PM EDT  Shares of Valneva SE (VALN) are gaining over 15% on Wednesday morning, continuing its rally from Monday, when the French biotech company reported that its coronavirus vaccine candidate performed better compared to AstraZeneca's vaccine in a trial.   RTTNews
06:28AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 06.00 A.M. EDT).   RTTNews
Oct 19, 2021
06:03AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 05.50 A.M. EDT).   RTTNews
Oct 18, 2021
02:37PM EDT  Mid-Afternoon Market Update: Dow Falls 70 Points; Evolving Systems Shares Spike Higher   Benzinga
12:56PM EDT  Mid-Day Market Update: Nasdaq Rises 50 Points; Revance Therapeutics Shares Plummet   Benzinga
10:28AM EDT  Mid-Morning Market Update: Markets Mostly Lower; Albertsons Tops Q2 Estimates   Benzinga
10:05AM EDT  Shares of Valneva SE (VALN) are surging over 35% on Monday morning after the French biotech company said that its coronavirus vaccine candidate performed better compared to AstraZeneca's vaccine in a trial.   RTTNews
06:44AM EDT  The following are some of the stocks making big moves in Monday's pre-market trading (as of 06.30 A.M. EDT).   RTTNews
05:16AM EDT  Shares of Valneva Rise 34% After Company Reports Endpoints Met in Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate; Shares of Dynavax, Supplier of CpG 1018 Adjuvant, Up 7%   Benzinga
01:14AM EDT  Valneva Reports Positive Topline Results From Phase 3 Cov-Compare Trial COVID-19 Vaccine Candidate, VLA2001   RTTNews
Oct 11, 2021
06:08AM EDT  The following are some of the stocks making big moves in Monday's pre-market trading (as of 5.55 A.M. EDT).   RTTNews
Oct 4, 2021
03:15PM EDT  Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating claims of violations of federal securities laws on behalf of investors of Valneva SE (Valneva or the Company) (NASDAQ: VALN; Euronext Paris: VLA). If you are a shareholder of Valneva with more than $50,000 in losses, you should contact the Firm.   GlobeNewswire Inc
Sep 28, 2021
01:26AM EDT  Valneva SE (VALN) and Pfizer Inc. (PFE) announced further positive Phase 2 results, including booster response, for Lyme disease vaccine candidate VLA15. The study is continuing to monitor persistence of antibody responses.   RTTNews
01:06AM EDT  Valneva, Pfizer Announce Further Positive Phase 2 Results For Lyme Disease Vaccine Candidate VLA15   RTTNews
Sep 23, 2021
01:27AM EDT  Valneva SE (VALN) said that it has commenced recruitment of adolescents in its pivotal Phase 3 Clinical Trial (VLA2001-301) for its inactivated COVID-19 vaccine candidate VLA2001 in the United Kingdom.   RTTNews
01:08AM EDT  Valneva Begins Recruitment Of Adolescents In Phase 3 Trial For Inactivated COVID-19 Vaccine Candidate VLA2001 In U.K.   RTTNews
Sep 14, 2021
01:04AM EDT  Valneva Completes Recruitment Of Elderly Participants In Phase 3 Trial Of Inactivated COVID-19 Vaccine   RTTNews
Sep 13, 2021
02:40PM EDT  Mid-Afternoon Market Update: Dow Rises Over 100 Points; Itamar Medical Shares Spike Higher   Benzinga
12:17PM EDT  Mid-Day Market Update: Crude Oil Up 1%; MiMedx Group Shares Plummet   Benzinga
10:29AM EDT  Mid-Morning Market Update: Markets Mixed; UK Terminates Valneva's COVID-19 Vaccine Contract   Benzinga
10:09AM EDT  Why Dynavax Shares Are Trading Lower Today   Benzinga
06:10AM EDT  The following are some of the stocks making big moves in Monday's pre-market trading (as of 5.45 A.M. EDT).   RTTNews
01:06AM EDT  Valneva Gets Termination Notice From UK Government For COVID-19 Vaccine, VLA2001 Supply Deal   RTTNews
Sep 7, 2021
06:25AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 6.10 A.M. EDT).   RTTNews
Sep 5, 2021
01:14PM EDT  The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week   Benzinga
Sep 3, 2021
01:04AM EDT  Valneva Announces U.S. DoD Exercises First Year Option On IXIARO Supply Contract   RTTNews
Sep 1, 2021
06:07AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.45 A.M. EDT).   RTTNews
Aug 23, 2021
02:53AM EDT  Valneva SE (VALN) said that it commenced rolling submission, for initial approval of its COVID-19 vaccine candidate, VLA2001, with the Medicines and Healthcare products Regulatory Agency in the United Kingdom.   RTTNews
02:36AM EDT  Valneva Commences Rolling Submission With MHRA In UK For COVID-19 Vaccine Candidate, VLA2001   RTTNews
Aug 10, 2021
01:26AM EDT  Valneva H1 Net Loss EUR 86.4 Mln Vs Loss EUR 25.6 Mln Prior Year   RTTNews
Aug 5, 2021
06:48AM EDT  Valneva's Chikungunya Vaccine Candidate Shows Protective Neutralizing Antibodies In Late-Stage Trial   Benzinga
Jul 7, 2021
02:20PM EDT  Valneva's Chikungunya Vaccine Candidate Gets FDA Breakthrough Tag   Benzinga
Jun 1, 2021
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2021   Benzinga
08:46AM EDT  Jefferies Initiates Coverage On Valneva with Buy Rating, Announces Price Target of $36   Benzinga
06:29AM EDT  Goldman Sachs Initiates Coverage On Valneva with Buy Rating, Announces Price Target of $34   Benzinga
May 28, 2021
08:02AM EDT  The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq   Benzinga
May 20, 2021
04:08AM EDT  Earnings Scheduled For May 20, 2021   Benzinga
May 6, 2021
10:01AM EDT  Valneva Shares Shares Open For Trade At $27.07; IPO Priced at $26.41/ADS   Benzinga
09:32AM EDT  Valneva Shares Will Open For Quote At 9:50 a.m. EST, Expected To Open For Trade After 10 a.m. EST; IPO Priced at $26.41/ADS   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC